Clinical Chimeric Antigen Receptor‐T Cell Therapy: A New and Promising Treatment Modality for Glioblastoma
Clinical and Translational Immunology - United Kingdom
doi 10.1002/cti2.1050
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2019
Authors
Publisher
Wiley